ALZA CORPORATION

ACTISITE

MEDICAMENTS FOR TREATMENT OF PERIODONTAL DISEASE;

ACTISITE

MEDICAMENTS FOR TREATMENT OF PERIODONTAL DISEASE;ACTI-SITE;

ADENZA

Pharmaceuticals, namely, opioid analgesics;medical device, namely, a patch powered by an electric power source for transdermally delivering drugs;

ALANTAR

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system;

ALZA

LABORATORY EQUIPMENT, NAMELY RELEASE RATE TESTERS;

ALZA

printed publications, namely, quarterly and annual financial reports, periodical news letters relating to pharmaceuticals; stationery and order forms;clothing, namely, t-shirts, hats and sweatshirts;The drawing is lined for the color blue.;

ALZA

pharmaceutical products, namely, those in specialized dosage forms, namely, transdermal plasters and transdermal patches used in pain relief, treatment of hypogonadism, and smoking cessation; iontophoretic patches for use in pain relief; controlled drug-releasing polymer matrices, for use in treatment of conditions of the oral cavity; and pharmaceutical products in conventional dosage forms, namely, fungicides, for treating oral fungal infections, alkalinizing agents for maintaining alkaline urine, alkalinizing agents for treating acidosis, alkalinizing agents for neutralizing gastric acid, bladder control drugs, anti-cancer drugs, drugs for relieving bladder pain, drugs for treating interstitial cystitis, drugs for reducing toxicity associated with chemotherapy, drugs for treating oral candidiasis, dietary and nutritional supplements, and drugs for use in the field of urology and oncology; and osmotic pumps for use in delivering cough/cold medications and for use in the field of urology and oncology;implantable drug delivery devices for use in experimental animals and for administering leuprolide in the treatment of prostate cancer;The drawing is lined for blue, but no claim for color is made.;

ALZA

product development, namely, developing pharmaceutical products in specialized dosage forms, namely, transdermal plasters, transmdermal patches, iontophoretic patches, osmotic pumps, controlled drug-releasing polymer matrices, and implantable drug delivery devices;The drawing is lined for the color blue.;

ALZA

Pharmaceuticals namely, pilocarpine for treating glaucoma, progesterone for contraception, oxybutynin for urinary and bladder conditions, methylphenidate for treatment of attention deficit disorder, systemic alkalizers, amifostine for treating toxic effects of chemotherapy, pentosan polysulfate sodium for treatment of interstitial cystitis, clotrimazole for treatment of fungal infections, and tetracycline for treatment of bacterial infections;medical devices namely, osmotic pumps, intrauterine devices, implantable periodontal fibers, implant implanting equipment and occular inserts;

ALZAMER

Polymers for Use in the Manufacture of Drugs;

ALZET

MINIATURE FLUID DISPENSERS FOR EXPERIMENTAL USE IN LABORATORY ANIMALS OR IN VITRO;

ALZET

Implantable and Non-Implantable Pumps for Use in Dispensing Fluids into Small Animals;

AR/MED

MEDICAL INFUSORS AND COMPONENTS THEREOF;

AXURA

- Pharmaceutical, veterinary, and sanitary substances; infants' and invalids' foods; plaster materials for bandaging; material for stopping teeth, dental wax, disinfectants; preparations for killing weeds and destroying vermin;Surgical, medical, dental, and veterinary instruments and apparatus (including artificial limbs, eyes, and teeth);

BDI

research and development services in the field of administration of proteins or peptides;

CHRONSET

CHRON-SET;product development service in the field of [ human and ] veterinary drug delivery systems;

CONCENTRA

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system;CONCENTRATION;

CONCERTA

Pharmaceutical preparations for the treatment of disease and disorders of the central nervous system;CONCERT A;

COVANZA

Pharmaceuticals, namely, opioid analgesics;medical device, namely, a patch powered by an electric power source for transdermally delivering drugs;

D-TRANS

D TRAINS;product development services in the field of transdermal drug delivery systems;

D-TRANS

TRANSDERMAL PATCHES FOR TESTOSTERONE HORMONE THERAPY AND FOR THE TREATMENT OF PAIN;D TRANS;

DAYSTEL

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system;

DELIVERY TIMES

periodical magazine for employees in the pharmaceutical field;DELIVERY;

DITRODERM

Transdermal patch for treatment of incontinence;

DITROPAN

ANTISPAMODIC;

DITROPAN

Pharmaceuticals, namely oxybutynin;

DITROPAN CR

Pharmaceutical preparations, namely, a controlled release form of oxybutynin for the treatment of urge urinary incontinence and overactive bladder;CR;

DITROPAN XL

Pharmaceutical preparations, namely, a controlled release form of oxybutynin for the treatment of urge urinary incontinence and overactive bladder;

DITROPATCH

Transdermal patch for treatment of incontinence;DITRO PATCH;

DITROTRANS

Transdermal patch for treatment of incontinence;DITRO TRANSDERMAL;

DUROS

product development services in the field of drug delivery systems;

DUROS

medical and/or veterinary apparatus, namely, an implant for use in drug delivery; an implanter, namely, an implement for implanting the drug delivery implant; and/or kits containing medical supplies for the implant procedure as well as said implanters and/or implants;

DUROS

implantable pharmaceutical [ and/or veterinary ] preparations, namely, protein [ and/or peptide ] preparation for use in the delivery of pharmaceutical drugs;

E-TRANS

product development services in the field of drug delivery systems;

E-TRANS

electrically-assisted transdermal drug delivery systems, namely, iontophoretic drug delivery systems, electroosmotic drug delivery systems, and electroporation drug delivery systems;E TRANS;

E-TRANS

E TRANS;product development for others in the field of drug delivery systems;

ELLEGARD

Intrauterine hormone replacement products;

ETS

product development service in the field of human and veterinary drug delivery systems;

EUPREL

Pharmaceutical preparations, namely, an LH-RH agonist preparations for use in the treatment of cancer; implantable drug delivery systems comprised of an impermeable reservoir, a piston, a water-swellable agent formulation, an LH-RH agonist formulation, a semi-permeable plug, and a back-diffusion regulating outlet for use in the treatment of cancer;

EVIDOR

Pharmaceuticals, namely, opioid analgesics;medical device, namely, a patch powered by an electric power source for transdermally delivering drugs;

EXELA

Pharmaceutical and veterinary preparations, namely, an LH-RH agonist preparation for use in the treatment of cancer; implantable drug delivery systems comprised of an impermeable reservoir, a piston, a water-swellable agent formulation, an LH-RH agonist formulation, a semi-permeable plug, and a back-diffusion regulating outlet;

FENTRAN

Pharmaceuticals, namely, opioid analgesics;medical device, namely, a patch powered by an electric power source for transdermally delivering drugs;

FLEXERIL

MUSCLE RELAXANT AND TRANQUILIZER;FLEX ERIL;

G P A

computer programs, namely programs for conducting performance evaluations;reports generated by worker performance evaluation programs and instructions for the use of the programs;

IVOS

Intravenous Administration Apparatus;

L-OROS

Osmotic drug delivery platforms, consisting of a liquid drug layer, osmotic engine and semipermeable membrane coating, for the slow release of liquid drug formulations;

MACROFLUX

Product development for others in the field of transdermal drug delivery systems and transdermal analyte sampling systems;

MACROFLUX

Transdermal patches for sampling glucose, sold without medication; transdermal drug patches sold with medication; iontophoretic drug delivery devices, namely, iontophoresis electrodes, iontophoresis dispersive pads, and iontophoresis apparatus which generates an electric current for the delivery of drugs through the skin, sold with medication; intradermal drug delivery devices sold with medication;Iontophoretic drug delivery devices, namely, iotophoresis electrodes, iontophoresis dispersive pads, and iontophoresis apparatus which generates an electric current for the delivery of drugs through the skin, sold without medication; intradermal drug delivery devices sold without medication;

METRIPLAST